Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1204-1214

  Schentag, Jerome J ^a   Hyatt, Judith M ^b   Carr, James R ^b   Paladino, Joseph A ^b   Birmingham, Mary C ^b   Zimmer, Gabrial S ^b   Cumbo, Thomas J ^b  

^a Millard Fillmore Gates Circle Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; DRUG USE; ENTEROCOCCUS FAECALIS; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

EID: 0031901308     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520287     Document Type: Article

References (26)

1. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257:1050-5.
2. Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064-72.
3. Coronado VG, Edwards JR, Culver DH, Gaynes RP, and the NNIS. Ciprofloxacin resistance among Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1995;16:71-5.
4. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin resistant Staphylococcus aureus in US hospitals 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-8.
5. Gaynes RP, Culver DH, Horan TC, Henderson TS, Toison JS, Martone WJ. Trends in MRSA in United States hospitals. Infect Dis Clin Practice 1994;2:452-5.
6. Mulligan ME, Murray-Leisure K, Ribner BS, et al. Methicillin resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.
7. Boyce JM. Methicillin resistant Staphylococcus aureus in hospitals and long term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol 1992;13:725-37.
8. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
9. Duckworth G, Heathcock R. Br Soc Antimicrob Chemotherapy Working Party Report. Guidelines on the control of methicillin resistant Staphylococcus aureus in the community. J Hosp Infect 1995;31:1-12.
10. Casewell MW, Hill RLR. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986;18 Suppl A:1-12.
11. Saravolatz LD, Pohlhod DJ, Arking LM. Community acquired MRSA infections: a new source for nosocomial outbreaks. Ann Intern Med 1982;97:325-9.
12. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 1986;315:91-6.
13. Kluytmans JAJW, Mouton JW, Ijzerman EPF, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995;171:216-9.
14. O'Brien TF, Acar JF, Medieros AA, Norton RA, Goldstein F, Kent RL. International comparison of prevalence of resistance to antibiotics. JAMA 1979;239:1518-23.
15. Finland M. Emergence of antibiotic resistance in hospitals, 1935-1975. Rev Infect Dis 1979;1:4-21.
16. Ishikawa S, Hisada M, Mashita K, Mizuno A, Shinagawa N, Yura J. Changes of susceptibility of Staphylococcus aureus by prophylactic use of antibiotics in abdominal surgery [abstract no 897]. In: Abstracts of the 11th international Congress of Chemotherapy (Stockholm). 1993.
17. Chetchotisakd P, Phelps CL, Hartstein AI. Assessment of bacterial cross-transmission as a cause of infections in patients in intensive care units. Clin Infect Dis 1994;18:929-37.
18. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234-40.
19. Boyce JM. Should we vigorously try to contain and control methicillin resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46-54.
20. Edmond MB, Wenzel RB, Pasculle AW. Vancomycin resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med 1996;124:329-34.
21. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by MRSA. Ann Intern Med 1982;97:309-17.
22. Chambers HF. Treatment of infection and colonization caused by MRSA. Infect Control Hosp Epidemiol 1991;12:29-35.
23. Thomsberry C. Methicillin-resistant (hetero-resistant) staphylococci. Antimicrobic Newsletter 1984;6:43-50.
24. Kernodle DS. Surgical prophylaxis: How far have we really come? Pharmacotherapy 1988;8 (suppl):11S-3S.
25. Handwerger S, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 1985;7:368-86.
26. Mest DR, Wong DH, Shimoda KJ, et al. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 1994;78:644-50.